Showing 2631-2640 of 8920 results for "".
Full-Face Rejuvenation: Surface to Shape
https://practicaldermatology.com/topics/general-topics/full-face-rejuvenation-surface-to-shape/18576/DermTube Journal Club host Nancy Samolitis, MD interviews Sabine Zenker, MD about her approach to full-face rejuvenation to address patients' concerns about changes on the surface of their skin to the structure. Dr. Zenker says facial rejuvenation needs to address skin quality, wrinkles and rhytids,Topical Toxins: Now and Later
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/topical-toxins-now-and-later/18768/Topical neurotoxins are in late-stage development, with the potential to offer "softer" results and reduction of fine wrinkles. But they may not be approved for another few years. In the meantime, micro channel delivery of toxins, such as with AquaGold, is an option. Joel Schlessinger, MD, founder oNextech: A Specialized, All-in-One Solution
https://practicaldermatology.com/topics/general-topics/nextech-a-specialized-all-in-one-solution/18919/Specialty practices don't need canned solutions to their EMR needs, says dermatologist Saif Sayed of Skincare Specialty Physicians. He left a general EMR for Nextech, which provides "rich capability" to customize the EHR to his practice needs and his approach to patient care. From streamlining officMusic City SCALE Wrap-Up
https://practicaldermatology.com/conferences/scale-2024/music-city-scale-wrap/26555/Music City SCALE Wrap-UpTake 5
https://practicaldermatology.com/columns/take-5/take-5/21798/Currents: Getting To Know JAKs and Other Emerging Therapies
https://practicaldermatology.com/topics/psoriasis/currents-getting-to-know-jaks-and-other-emerging-therapies/23315/DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-3-year-clinical-data-lebrikizumab/28648/Study author Melinda Gooderham, MSc, MD, FRCPC, discusses the new three-year clinical data presented at the European Academy of Dermatology & Venereology (EADV) Congress on the efficacy and safety of lebrikizumab, which the FDA recently approved on September 13 for adults and adolescents with moNIH Analysis Examines Association Between AD and Comorbidities
https://practicaldermatology.com/programs/practical-dermatology-atopic-dermatitis/nih-analysis-examines-association-between-ad-and-comorbidities/27113/In this week's DermwireTV, new NIH data looks at the association between AD and several health conditions; a study evaluates the effect of lebrikizumab monotherapy in patients with moderate-to-severe AD over 16 weeks; and Andrew Mastro provides tips on how to optimize the first 5 minutes with a patiScientifically Speaking: Effective By Design with Josh Makower, MD
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-effective-by-design-with-josh-makower-md/20106/Josh Makower, MD has been at the forefront of several medical innovations. Listen in as he describes his approach and discusses his latest product with host Joel L. Cohen, MD. The Avéli device from Revelle Aesthetics is FDA-cleared to reduce cellulite in the buttocks and thighs temporarily.Scientifically Speaking: Can We Conquer Cellulite?
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-can-we-conquer-cellulite/19872/Treating cellulite has been a challenge, but new and emerging technologies offer hope to overcome this common condition. Host Joel L. Cohen, MD talks with Nazanin Saedi, MD, Endo's Mike McLane, PhD, and Soliton's Wally Klemp.